Andreas Nägeli
Head of Business Development Genovis
Seminars
Wednesday 10th March 2027
GlyCLICK®: A Versatile Conjugation Platform for Improved ADCs
1:00 pm
- Introducing GlyCLICK® as an enzymebased platform for precise, site-specific antibody conjugation
- Enabling highly homogeneous ADCs* with defined DARs while preserving antibody function
- Supporting controlled and scalable ADC generation across a broad range of antibody formats and payloads
